| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/24/2006 | WO2006032885A3 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 08/24/2006 | WO2006018723A3 Androgen modulators |
| 08/24/2006 | US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189609 1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 08/24/2006 | US20060188636 Papaya puree and the use of the same |
| 08/24/2006 | US20060188571 Mixing progesterone with water and adjuvants; drying; compaction |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | CA2597269A1 1-substituted-7-(beta-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 08/23/2006 | EP1693365A1 Inhibitors of dipeptidyl peptidase IV |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1692101A1 Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof |
| 08/23/2006 | EP1485391B1 Phosphate transport inhibitors |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1404309B1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl| propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy| phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug |
| 08/23/2006 | EP1402913B1 Dry powder inhalation system for transpulmonary administration, method of manufacturing a dry powdered preparation, and use of a freeze dried composition |
| 08/23/2006 | EP1276867B1 Use of human latrophilin-like G protein-coupled receptor in screening methods |
| 08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
| 08/23/2006 | EP1237537B1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 08/23/2006 | EP1178824B1 Staphylococcus aureus antigen-containing whole cell vaccine |
| 08/23/2006 | CN1823076A Silicon compounds and their use |
| 08/23/2006 | CN1820783A Thyroid hormone medicinal preparation |
| 08/23/2006 | CN1820782A Thyroid hormone medicinal preparation and its preparing method |
| 08/23/2006 | CN1271086C GLP-1 derivs. |
| 08/23/2006 | CN1270713C Synergistic pharmaceutical combination for prevention or treatment of diabetes |
| 08/22/2006 | US7094887 UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 |
| 08/22/2006 | US7094872 Activated polyethylene glycol esters |
| 08/22/2006 | US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets |
| 08/17/2006 | WO2006085692A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/17/2006 | WO2006085100A1 Treatment of very low birthweight (vlbw) infants by increasing blood insulin levels |
| 08/17/2006 | WO2006084937A1 Method for diagnosing and treating women with increased response to hormonal replacement therapy |
| 08/17/2006 | WO2006084888A2 C-terminally pegylated growth hormones |
| 08/17/2006 | WO2006023158A3 Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds |
| 08/17/2006 | US20060183931 Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 08/17/2006 | US20060183784 Human growth hormone antagonists |
| 08/17/2006 | US20060183736 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 08/17/2006 | US20060183734 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
| 08/17/2006 | US20060183668 Novel insulin derivatives |
| 08/17/2006 | DE10159120B4 Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung Steroid hormone-containing transdermal therapeutic systems containing Propylenglycolmonocaprylat and its use |
| 08/17/2006 | CA2597541A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/16/2006 | EP1690874A2 BMP-12, BMP-13 and tendon-inducing compositions thereof |
| 08/16/2006 | EP1689864A2 Method and compositions for treating 5alpha-reductase type 1 and type 2 dependent conditions |
| 08/16/2006 | EP1689748A1 Novel 8-(piperazine-1-yl)- and 8-( 1,4|diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug |
| 08/16/2006 | EP1689383A2 Novel phosphorus-containing thyromimetics |
| 08/16/2006 | EP1337247B1 Use of Gaboxadol for the treatment of premenstrual disorder, postnatal depression or postmenopausal related dysphoric disorder |
| 08/16/2006 | EP1183020B1 (3-trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin resistance and type 2 diabetes |
| 08/16/2006 | EP1104675B1 Iodinated proteins for preventing iodine-deficit conditions |
| 08/16/2006 | EP1058726B1 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1819829A Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 08/16/2006 | CN1817906A Antibody against human parathormone related peptides |
| 08/16/2006 | CN1817854A Amino acids with affinity for the alpha-2-delta protein |
| 08/16/2006 | CN1269942C Hops extracts, method for prodn. and use |
| 08/16/2006 | CN1269836C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 08/15/2006 | US7091368 Method for the purification of liponic acid |
| 08/15/2006 | US7091234 Thio-oxindole derivatives |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091187 Using steroid; autoimmune disease |
| 08/15/2006 | US7090871 Composition containing pyrrolizidine-alkaloid-free petasites |
| 08/15/2006 | US7090864 Non-invasive gene targeting to ocular cells |
| 08/10/2006 | WO2006083618A1 NANDROLONE 17ß-CARBONATES |
| 08/10/2006 | WO2006083005A1 Fused pyrimidine derivative and used thereof |
| 08/10/2006 | WO2006018850A3 Compositions for treating amyloid associated diseases |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060178315 For therapy of immune or autoimmune diseases |
| 08/10/2006 | US20060178310 Intracellular delivery of biological effectors |
| 08/10/2006 | DE102005005446A1 Bruchfeste Darreichungsformen mit retardierter Freisetzung Unbreakable dosage forms with delayed release |
| 08/10/2006 | CA2590549A1 Therapeutic agent for polycystic ovary syndrome (pcos) |
| 08/09/2006 | EP1688434A1 Antibody and use of the same |
| 08/09/2006 | EP1688149A1 Paste formulations comprising silica |
| 08/09/2006 | EP1688134A2 Dry powder inhaler for transpulmonary administration |
| 08/09/2006 | EP1688133A1 Freeze-dried composition for transpulmonary administration |
| 08/09/2006 | EP1687027A1 Human anti il-15 antibody 146b7 inducing monocytes apoptosis, therapeutical uses thereof |
| 08/09/2006 | EP1537114B1 Organic compounds as agents for the treatment of aldosterone mediated conditions |
| 08/09/2006 | EP1456351B1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
| 08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
| 08/09/2006 | EP1144003B1 Methods and devices for delivery of agents to breast milk ducts |
| 08/09/2006 | EP1012177B1 Estrogen receptor |
| 08/09/2006 | CN1816341A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/09/2006 | CN1814200A Compound preparation for treating children's sexual precocity |
| 08/09/2006 | CN1268614C Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 08/09/2006 | CN1268396C Compositions of estrogen-cyclodextrin complexes |
| 08/09/2006 | CN1268394C Binding domain-immunoglobulin fusion proteins |
| 08/09/2006 | CN1268323C Rhodiola sacra soft capsule and its preparation |
| 08/09/2006 | CN1268319C Rhodiola sacra injection and its preparation |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087726 Anti-interferon-α antibodies |
| 08/08/2006 | US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation |
| 08/08/2006 | US7087634 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087591 21-substituted progesterone derivatives as new antiprogestational agents |
| 08/08/2006 | US7087400 Using a 11 beta-reductase inhibitor in the manufacture of a medicament for control of 11-keto steroid conversion to 11 beta-hydroxysteroid in vivo |
| 08/08/2006 | US7087246 Controlled release preparation of insulin contains microparticles obtained by microencapsulation of uniform microcystals of insulin using biodegradable polymeric materials. Since the denaturation of insulin that may occur |